ARTICLE | Finance
Wale(s) of experience
Arthurian plans 10-12 drug, Dx, medtech investments for Welsh fund
February 4, 2013 8:00 AM UTC
A group of seasoned life science investors, academics and former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences. The group's first task is managing the recently created Welsh Life Sciences Fund.
The Welsh government committed £50 million ($78.7 million) to the fund last year and recently awarded Arthurian a contract to manage the fund. Arthurian board member Martin Walton told BioCentury the firm is now raising matching private funds for a total of £100 million ($157.4 million)...